GIP-induced vasodilation in human adipose tissue involves capillary recruitment

GIP-induced vasodilation in human adipose tissue involves capillary recruitment

Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia increase blood flow and triglyceride clearance in subcutaneous abdominal adipose tissue in lean humans. The present experiments were performed to determine whether the increase involves capillary recruitment. Eig...

Full description

Bibliographic Details
Main Authors:	Meena Asmar, Ali Asmar, Lene Simonsen, Flemming Dela, Jens Juul Holst, Jens Bülow
Format:	Article
Language:	English
Published:	Bioscientifica 2019-06-01
Series:	Endocrine Connections
Subjects:	glucose dependent insulinotropic polypeptide adipose tissue blood flow ultrasonic imaging microcirculation
Online Access:	https://ec.bioscientifica.com/view/journals/ec/8/6/EC-19-0144.xml

Similar Items

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
by: Sara Baldassano, et al.
Published: (2019-08-01)

The study of metabolic improvement by nutritional intervention controlling endogenous GIP (Mini Egg study): a randomized, cross-over study
by: Naoki Sakane, et al.
Published: (2019-09-01)

The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor
by: Suleiman Al-Sabah, et al.
Published: (2020-08-01)

Glucose‐dependent insulinotropic polypeptide deficiency reduced fat accumulation and insulin resistance, but deteriorated bone loss in ovariectomized mice
by: Satoko Shimazu‐Kuwahara, et al.
Published: (2019-07-01)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
by: David S. Mathiesen, et al.
Published: (2019-08-01)

Effects of passage through the digestive tract on incretin secretion: Before and after birth
by: Seiichi Tomotaki, et al.
Published: (2021-06-01)

Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
by: Yu-Wen Yu, et al.
Published: (2018-04-01)

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
by: Nadya M. Morrow, et al.
Published: (2021-09-01)

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021-04-01)

GIPR Signaling in Immune Cells Maintains Metabolically Beneficial Type 2 Immune Responses in the White Fat From Obese Mice
by: Irina Efimova, et al.
Published: (2021-02-01)

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis
by: Gemma Pujadas, et al.
Published: (2020-09-01)

Serum and expression profiles of glucose-dependent insulinotropic polypeptide in correlation with cardiometabolic risk factors among patients with systemic lupus erythematosus
by: Nearmeen M Rashad, et al.
Published: (2019-01-01)

Effects of passage through the digestive tract on incretin secretion: Before and after birth
by: Tomotaki, Seiichi
Published: (2021)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
by: Soyeon Yoo, et al.
Published: (2021-06-01)

GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene
by: Su-Jin Kim, et al.
Published: (2010-11-01)

DOES PALM MID FRACTION AFFECT ADULT SATIETY?
by: Lee, V.K.M, et al.
Published: (2021)

Liver blood dynamics after bariatric surgery: the effects of mixed-meal test and incretin infusions
by: Henri Honka, et al.
Published: (2018-07-01)

Anti-obesity effects of galla rhois via genetic regulation of adipogenesis
by: Si Hyeung Yi, et al.
Published: (2021-10-01)

Serum Levels of Incretin Hormones – GLP-1 and GIP in Patients with Type 1 Diabetes Mellitus
by: Stanchev Pavel E., et al.
Published: (2019-03-01)

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
by: Fenghui Zhao, et al.
Published: (2021-07-01)

Insulin Secretion and Incretin Hormone Concentration in Women with Previous Gestational Diabetes Mellitus
by: Sung Hoon Yu, et al.
Published: (2011-02-01)

Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
by: Danielle M. Fitzgerald, et al.
Published: (2019-01-01)

Finns det något värde i att mäta Peptide tyrosine tyrosine, Glucose-dependent insulinotropic polypeptide och Oxyntomodulin postprandialt vid måltidsstudier?
by: Andersson, Jeanette
Published: (2015)

Mécanismes et conséquences de l'internalisation du récepteur du "glucose-dependent insulinotropic polypeptide"
by: Ismail, Sadek
Published: (2016)

Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes
by: Tsuyoshi Yanagimachi, et al.
Published: (2020-04-01)

Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
by: Daiji Kawanami, et al.
Published: (2016-07-01)

Potential for Gut Peptide-Based Therapy in Postprandial Hypotension
by: Malcolm J. Borg, et al.
Published: (2021-08-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Vildagliptin: optimal control in type 2 diabetes mellitus treatment
by: Alexander Sergeevich Ametov
Published: (2015-10-01)

A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide-expressing cells in the hypothalamus
by: Adriaenssens, A., et al.
Published: (2022)

Structure/function studies of the extracellular domains of the glucagon-like peptide-1 receptor
by: LoÌpez de Maturana Garmendia, Rakel
Published: (2002)

Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP‐1 but not GIP, CCK, and gastrin in plasma
by: Ali Asmar, et al.
Published: (2020-08-01)

Diet-Induced Obese Mice and Leptin-Deficient <i>Lep<sup>ob/ob</sup></i> Mice Exhibit Increased Circulating GIP Levels Produced by Different Mechanisms
by: Eunyoung Lee, et al.
Published: (2019-09-01)

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
by: Miaad Bader, et al.
Published: (2020-01-01)

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
by: Shu-Chen Lu, et al.
Published: (2021-05-01)

Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses
by: Line Engelbrechtsen, et al.
Published: (2018-03-01)

GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
by: Baggio, L.L, et al.
Published: (2022)

Possibilities of vildagliptin in optimal control of type 2 diabetes mellitus
by: V.I. Pankiv
Published: (2019-09-01)

Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
by: E A Shestakova, et al.
Published: (2014-10-01)

Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
by: Jared Rosenberg, et al.
Published: (2021-09-01)